Similar articles

• Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: still a valid treatment in appropriately selected patients.

  Betts TR. Betts TR. Europace. 2008 Apr;10(4):425-32. doi: 10.1093/europace/eun063. Epub 2008 Mar 12. Europace. 2008. PMID: 18339612 Review.
• Prospective, randomized study of atrioventricular node ablation and mode-switching, dual chamber pacemaker implantation using two different algorithms in patients with paroxysmal atrial fibrillation.

  Marshall HJ, Harris ZI, Griffith MJ, Gammage MD. Marshall HJ, et al. Europace. 1999 Jan;1(1):20-1. doi: 10.1053/eupc.1998.0003. Europace. 1999. PMID: 11220533 Clinical Trial. No abstract available.
• [Guidelines for the management of patients with atrial fibrillation. Executive summary].

  Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Neal Kay G, Lowe JE, Bertil Olsson S, Prystowsky EN, Tamargo JL, Wann S. Fuster V, et al. Rev Esp Cardiol. 2006 Dec;59(12):1329. Rev Esp Cardiol. 2006. PMID: 17194429 Spanish. No abstract available.
• Atrial fibrillation.

  Falk RH. Falk RH. N Engl J Med. 2001 Apr 5;344(14):1067-78. doi: 10.1056/NEJM200104053441407. N Engl J Med. 2001. PMID: 11287978 Review. No abstract available.
• Resumption of atrioventricular conduction by levosimendan after radiofrequency ablation of the AV node:

  Maury P, Baixas C, Roncalli J, Couderc P, Delay M, Pathak A, Galinier M. Maury P, et al. Pacing Clin Electrophysiol. 2004 Sep;27(9):1314-6. doi: 10.1111/j.1540-8159.2004.00626.x. Pacing Clin Electrophysiol. 2004. PMID: 15461725